Steven M. Rowe, M.D., MSPH, has been named director of the Gregory Fleming James Cystic Fibrosis Research Center in the UAB School of Medicine, effective Aug. 1.
Chad Steele, Ph.D., professor of Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine, has been named assistant dean for Research Administration, a new position in the School of Medicine created to facilitate successful onboarding for faculty.
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
A UAB researcher suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis.
In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock’s left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr® endobronchial valve.
William C. Bailey, professor in the Division of Pulmonary, Allergy and Critical Medicine at the University of Alabama at Birmingham, has been awarded a Lifetime Achievement Award for 50 years of exemplary service by the Tulane Medical Alumni Association.
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
UAB gets $11 million grant for potential groundbreaking study of beta blockers for patients with COPD.
UAB discovery gives better understanding of and potential therapies for septic shock and reperfusion injuries.
Page 1 of 3